Form DEF 14A Quoin Pharmaceuticals Ltd. For: 16 July
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Quoin Pharmaceuticals Ltd DRC (QNRX)
The Quoin Pharmaceuticals DRC share price today is 4.6209, view NASDAQ QNRX stock exchange data. Track the latest Quoin Pharmaceuticals DRC share price with real-time updates on QNRX stock performance including market cap, day range, 52-week range and dividend yield. Access QNRX charts, earnings dates and analyst estimates to support your investment decisions.
4.6209
-0.3491(-7.02%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.6209
4.9550
52 wk Range
3.2500
41.8000
QNRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.62094.9550
52 wk Range
3.250041.8000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
QNRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
21.4000
Upside
+363.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Form PRE 14A Quoin Pharmaceuticals Ltd. For: 6 July- Investing.com
- Form DEF 14A Quoin Pharmaceuticals Ltd. For: 16 July
- Investing.com
- Form PRE 14A Quoin Pharmaceuticals Ltd. For: 6 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 21.4000
(+363.11% Upside)
Earnings
Latest Release
07-05-2026
EPS / Forecast
-1.77 / -1.96
Revenue / Forecast
-- / --
Compare QNRX to Peers and Sector
Metrics to compare | QNRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQNRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −2.0x | −0.3x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | 2.4x | 3.9x | 2.6x | |
Price / LTM Sales | - | 40.1x | 3.1x | |
Upside (Analyst Target) | 239.0% | 191.2% | 50.4% | |
Fair Value Upside | Unlock | 2.3% | 6.4% | Unlock |
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Quoin Pharmaceuticals DRC (QNRX) Share Price Today?
The Quoin Pharmaceuticals DRC share price today is 4.6209.
What is the current Quoin Pharmaceuticals DRC (QNRX) share price and day range?
As of 19-08-2026, the Quoin Pharmaceuticals DRC share price is 4.6209, with a previous close of 4.9700. The share price has ranged from 4.6209 to 4.9550 today, while the 52-week range spans from 3.2500 to 41.8000.
What Is the Quoin Pharmaceuticals DRC Market Cap?
As of today, Quoin Pharmaceuticals DRC market cap is 9.9800M.
What Is the Quoin Pharmaceuticals DRC (QNRX) Share Price Target?
The average 12-month share price target for Quoin Pharmaceuticals DRC is 21.4000, with a high estimate of 35 and a low estimate of 12. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +363.11% Upside potential.
From a Technical Analysis Perspective, Is QNRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Quoin Pharmaceuticals DRC Trade On?
Quoin Pharmaceuticals DRC is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Quoin Pharmaceuticals DRC?
The stock symbol for Quoin Pharmaceuticals DRC is "QNRX."
How Many Times Has Quoin Pharmaceuticals DRC Stock Split?
Quoin Pharmaceuticals DRC has split 3 times.
How Many Employees Does Quoin Pharmaceuticals DRC Have?
Quoin Pharmaceuticals DRC has 5 employees.
What Is the QNRX Premarket Price?
QNRX's last pre-market stock price is 5.2600. The pre-market share volume is 290.0000, and the stock has changed by 0.2900, or 5.8400%.
What Is the QNRX After Hours Price?
QNRX's last after hours stock price is 4.7500, the stock has changed by -0.2200, or -4.4300%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.